穿支动脉粥样硬化性疾病的诊治进展

doi:10.3969/j.issn.1673-5765.2020.12.015

摘要/Abstract

摘要：

穿支动脉粥样硬化性疾病（branch atheromatous disease，BAD）是引起急性孤立性皮层下梗死的常见且重要的病因，尤以亚洲人群多见。与脑小血管病所致腔隙性梗死比较，BAD相关梗死灶直径、形态学分布具有一定的特征性。BAD相关卒中急性期更易出现症状波动或神经功能恶化，早期预后不良。目前BAD仍缺乏统一的临床影像诊断标准，使得BAD临床研究及精准诊疗面临挑战。近期应用高分辨及高场强磁共振技术可同时显示载体动脉管壁和穿支动脉形态，未来有望突破BAD的发病机制研究的瓶颈。本文对BAD临床影像特征、诊断标准及防治策略等进行综述，以期提高临床医师的重视和认知水平。

文章导读： 穿支动脉粥样硬化性疾病是导致缺血性卒中的一种重要的病理机制，具有独特的临床、影像及预后特征。

关键词: 穿支动脉粥样硬化性疾病; 脑小血管病; 穿支动脉; 皮层下梗死; 单发; 早期神经功能恶化

Abstract:

Branch atheromatous disease (BAD), was supposed as one of the important etiology for acute isolated subcortical infarction, especially in Asian population. Compared with classic lacuna infarction due to cerebral small vessel disease, the diameter and morphological distribution of BAD related infarction have certain characteristics. Patients with BAD are more liable to have a fluctuating symptoms or experience early neurological deterioration and may have early poor prognosis. However, due to the fact that the existing imaging techniques cannot depict small vessel changes, the clinical diagnosis and research of BAD are facing challenges. Recently, the application of high resolution and high field magnetic resonance imaging can simultaneously depict the vessel wall of parent artery and the morphology of penetrating artery, which is expected to break through the bottleneck of the research on pathogenesis of BAD. This article reviewed the clinical and imaging features of BAD, diagnosis standards and treatment strategy for BAD, to raise the awareness of this disease for neurologists.

Key words: Branch atheromatous disease; Cerebral small vessel disease; Penetrating artery;Subcortical infarction; Isolated; Early neurological deterioration

周立新，倪俊. 穿支动脉粥样硬化性疾病的诊治进展[J]. 中国卒中杂志, 2020, 15(12): 1342-1351.

ZHOU Li-Xin, NI Jun. Advances in Branch Atheromatous Disease[J]. Chinese Journal of Stroke, 2020, 15(12): 1342-1351.

参考文献

[1] CAPLAN L R. Intracranial branch atheromatous

disease：a neglected，understudied，and underused

concept[J]. Neurology，1989，39（9）：1246-1250.

[2] CHUNG J W，KIM B J，SOHR C H，et al. Branch

atheromatous plaque：a major cause of lacunar

infarction（high-resolution MRI study）[J].

Cerebrovasc Dis Extra，2012，2（1）：36-44.

[3] GAO S，WANG Y J，XU A D，et al. Chinese

ischemic stroke subclassification[J/OL]. Front Neurol，

2011，2：6[2020-06-20]. https：//doi.org/10.3389/

fneur.2011.00006.

[4] NAKASE T，YOSHIOKA S，SASAKI M，et al.

Clinical evaluation of lacunar infarction and branch

atheromatous disease[J]. J Stroke Cerebrovasc Dis，

2013，22（4）：406-412.

[5] DEGUCHI I，HAYASHI T，KATO Y，et al.

Treatment outcomes of tissue plasminogen activator

infusion for branch atheromatous disease[J/

OL]. J Stroke Cerebrovasc Dis，2013，22（7）：

e168-e172[2020-06-20]. https：//doi.org/10.1016/j.jstr

okecerebrovasdis.2012.10.012.

[6] PARK M G，OH E H，KIM B K，et al. Intravenous

tissue plasminogen activator in acute branch

atheromatous disease：does it prevent early

neurological deterioration?[J/OL]. J Clin Neurosci，

2016，33：194-197[2020-06-20]. https：//doi.

org/10.1016/j.jocn.2016.04.011.

[7] FISHER C M. The vascular lesion in lacunae[J].

Trans Am Neurol Assoc，1965，90：243-245.

[8] FISHER C M，CAPLAN L R. Basilar artery

branch occlusion：a cause of pontine infarction[J].

Neurology，1971，21（9）：900-905.

[9] FISHER C M. Bilateral occlusion of basilar artery

branches[J]. J Neurol Neurosurg Psychiatry，1977，40

（12）：1182-1189.

[10] WONG K S，CAPLAN L R，KIM J S. Stroke

mechanisms[J/OL]. Front Neurol Neurosci，2016，40：58-71[2020-06-20]. https：//doi.

org/10.1159/000448302.

[11] ADACHI T，KOBAYASHI S，YAMAGUCHI S，et

al. MRI findings of small subcortical ‘lacunar-like’

infarction resulting from large vessel disease[J]. J

Neurol，2000，247（4）：280-285.

[12] BANG O Y，HEO J H，KIM J Y，et al. Middle

cerebral artery stenosis is a major clinical

determinant in striatocapsular small，deep

infarction[J]. Arch Neurol，2002，59（2）：259-263.

[13] MOK V C，FAN Y H，LAM W W，et al. Small

subcortical infarct and intracranial large artery

disease in Chinese[J]. J Neurol Sci，2003，216（1）：

55-59.

[14] TATSUMI S，YAMAMOTO T. An autopsied case of

an apparent pontine branch atheromatous disease[J].

Eur Neurol，2010，63（3）：184-185.

[15] KWAN M W，MAK W，CHEUNG R T，et al.

Ischemic stroke related to intracranial branch

atheromatous disease and comparison with large

and small artery diseases[J]. J Neurol Sci，2011，303

（1/2）：80-84.

[16] YAMAMOTO Y，OHARA T，HAMANAKA

M，et al. Characteristics of intracranial branch

atheromatous disease and its association with

progressive motor deficits[J]. J Neurol Sci，2011，304

（1/2）：78-82.

[17] LIU Y，FAN Y T，LIU Y M，et al. A retrospective

study of branch atheromatous disease：analyses of

risk factors and prognosis [J]. J Huazhong Univ Sci

Technolog Med Sci，2017，37（1）：93-99.

[18] KIM J S，LEE J H，IM J H，et al. Syndromes of

pontine base infarction. A clinical-radiological

correlation study[J]. Stroke，1995，26（6）：950-955.

[19] CHUNG C P，YONG C S，CHANG F C，et al.

Stroke etiology is associated with outcome in

posterior circulation stroke[J]. Ann Clin Transl

Neurol，2015，2（5）：510-517.

[20] YOON Y，LEE D H，KANG D W，et al. Stroke

recurrence patterns are predicted by the subtypes

and mechanisms of the past，non-cardiogenic

stroke[J]. Eur J Neurol，2013，20（6）：928-934.

[21] MEN X J，LI J J，ZHANG B J，et al. Homocysteine

and C-reactive protein associated with progression

and prognosis of intracranial branch atheromatous

disease[J/OL]. PLoS One，2013，8（9）：

e73030[2020-06-20]. https：//doi.org/1371/journal.

pone.0073030.

[22] CAPLAN L R. Diabetes and brain ischemia[J/OL].

Diabetes，1996，45（suppl 3）：S95-S97[2020-06-20].

https：//doi.org/10.2337/diab.45.3.s95.

[23] ZHOU L X，YAO M，PENG B，et al. Atherosclerosis

might be responsible for branch artery disease：

evidence from white matter hyperintensity burden in

acute isolated pontine infarction[J/OL]. Front Neurol，

2018，9：840[2020-06-20]. https：//doi.org/10.3389/

fneur.2018.00840.

[24] SUN S Y，WANG Y Q，WANG Y G，et al. Lipid

and hyperglycemia factors in first-ever penetrating

artery infarction，a comparison between different

subtypes[J/OL]. Brain Behav，2017，7（6）：

e00694[2020-06-20]. https：//doi.org/10.1002/

brb3.694.

[25] DONAN G A，O’MALLEY H M，QUANG L，et al.

The capsular warning syndrome[J]. Neurology，1993，

43（5）：957-962.

[26] ZHOU L X，NI J，XU W H，et al. High-resolution

MRI findings in patients with capsular warning

syndrome[J/OL]. BMC Neurol，2014，14：16[2020-

06-20]. https：//doi.org/10.1186/1471-2377-14-16.

[27] MATSUZONO K，SUZUKI M，FURUYA

K，et al. Hemichorea-hemiballism by branch

atheromatous disease with a unique cerebral blood

flow abnormality[J/OL]. J Neurol Sci，2018，393：

113-115[2020-06-20]. https：//doi.org/10.1016/

j.jns.2018.08.021.

[28] KIM D E，CHOI M J，KIM J T，et al. Two different

clinical entities of small vessel occlusion in TOAST

classification[J]. Clin Neurol Neurosurg，2013，115

（9）：1686-1692.

[29] JEONG H G，KIM B J，YANG M H，et al.

Neuroimaging markers for early neurologic

deterioration in single small subcortical infarction[J].

Stroke，2015，46（3）：687-691.

[30] NAKASE T，YAMAMOTO Y，TAKAG M，et

al. The impact of diagnosing branch atheromatous

disease for predicting prognosis[J]. J Stroke

Cerebrovasc Dis，2015，24（10）：2423-2438.

[31] DEL BENE A，PALUMBO V，LAMASSA M，et al.

Progressive lacunar stroke：review of mechanisms，

prognostic features，and putative treatments[J]. Int J

Stroke，2012，7（4）：321-329.

[32] SUTO Y，NAKAYASU H，MAEDA M，et al. Longterm

prognosis of patients with large subcortical

infarctions[J]. Eur Neurol，2009，62（5）：304-310.

[33] PETRONE L，NANNONI S，DEL BENE A，et

al. Branch atheromatous disease：a clinically

meaningful，yet unproven concept[J]. Cerebrovasc

Dis，2016，41（1/2）：87-95.

[34] FEEKES J A，HSU S W，CHALOUPKA J C，et

al. Tertiary microvascular territories define lacunar

infarcts in the basal ganglia[J]. Ann Neurol，2005，58 （1）：18-30.

[35] PHAN T G，VAN DER VOORT S，BEARE R，et al.

Dimensions of subcortical infarcts associated with

first- to third-order branches of the basal ganglia

arteries[J]. Cerebrovasc Dis，2013，35（3）：262-267.

[36] CAO Y Z，ZHANG M Y，ZHOU L X，et

al. Consecutive slides on axial view is more

effective than transversal diameter to differentiate

mechanisms of single subcortical infarctions in the

lenticulostriate artery territory[J/OL]. Front Neurol，

2019，10：336[2020-06-20]. https：//doi.org/10.3389/

fneur.2019.00336.

[37] NAH H W，KANG D W，KWON S U，et al.

Diversity of single small subcortical infarctions

according to infarct location and parent artery

disease：analysis of indicators for small vessel

disease and atherosclerosis[J]. Stroke，2010，41（12）：

2822-2827.

[38] MEN X J，WU A M，ZHANG B J，et al.

Leukoaraiosis and NIHSS score help to differentiate

subtypes of intracranial branch atheromatous disease

in Southern Han Chinese patients with stroke[J]

Neurol Sci，2013，34（10）：1727-1733.

[39] MIYAJI Y，KAWABATA Y，JOKI H，et al. Highresolution

magnetic resonance imaging findings

of basilar artery plaque in a patient with branch

atheromatous disease：a case report[J/OL]. J Med

Case Rep，2014，8：395[2020-06-20]. https：//doi.

org/10.1186/1752-1947-8-395.

[40] RYOO S，LEE M J，CHA J，et al. Differential

vascular pathophysiologic types of intracranial

atherosclerotic stroke：a high-resolution wall

magnetic resonance imaging study[J]. Stroke，2015，

46（10）：2815-2821.

[41] ZHANG Z H，FAN Z Y，KONG Q L，et al.

Visualization of the lenticulostriate arteries at 3T

using black-blood T1-weighted intracranial vessel

wall imaging：comparison with 7T TOF-MRA[J].

Eur Radiol，2019，29（3）：1452-1459.

[42] JIANG S，YAN Y Y，YANG T，et al. Plaque

distribution correlates with morphology of

lenticulostriate arteries in single subcortical

infarctions[J]. Stroke，2020，51（9）：2801-2809.

[43] RUTLAND J W，DELMAN B N，GILL C M，et al.

Emerging use of ultra-high-field 7T MRI in the study

of intracranial vascularity：state of the field and

future directions[J]. AJNR Am J Neuroradiol，2020，

41（1）：2-9.

[44] MURAYAMA K，SUZUKI S，NAGATA H，et

al. Visualization of lenticulostriate arteries on

CT angiography using ultra-high-resolution CT

compared with conventional-detector CT[J]. AJNR

Am J Neuroradiol，2020，41（2）：219-223.

[45] ADAMS H P，BENDIXEN B H，KAPPELLE L J，et

al. Classification of subtype of acute ischemic stroke.

Definitions for use in a multicenter clinical trial[J].

Stroke，1993，24（1）：35-41.

[46] HART R G，DEINER H C，COUTTS S B，et al.

Embolic strokes of undetermined source：the case for

a new clinical construct[J]. Lancet Neurol，2014，13

（4）：429-438.

[47] UCHIYAMA S，TOYODA K，KITAGAWA K，et al.

Branch atheromatous disease diagnosed as embolic

stroke of undetermined source：a sub-analysis of

NAVIGATE ESUS[J]. Int J Stroke，2019，14（9）：

915-922.

[48] MUSTANOJA S，MERETOJA A，PUTAALA J，et

al. Outcome by stroke etiology in patients receiving

thrombolytic treatment：descriptive subtype

analysis[J]. Stroke，2011，42（1）：102-106.

[49] YAMAMOTO Y，NAGAKANE Y，MAKINO M，

et al. Aggressive antiplatelet treatment for acute

branch atheromatous disease type infarcts：a 12-year

prospective study[J/OL]. Int J Stroke，2014，9（3）：

E8[2020-06-20]. https：//doi.org/10.1111/ijs.12200.

[50] KIMURA T，TUCKER A，SUGIMURA T，et al.

Ultra-early combination antiplatelet therapy with

cilostazol for the prevention of branch atheromatous

disease：a multicenter prospective study[J].

Cerebrovasc Dis Extra，2016，6（3）：84-95.

[51] LI W，WU Y，LI X S，et al. Intravenous tirofiban

therapy for patients with capsular warning

syndrome[J]. Stroke Vasc Neurol，2019，4（1）：22-

27.

[52] PHILIPPS J，THOMALLA G，GLAHN J，et al.

Treatment of progressive stroke with tirofiban--

experience in 35 patients[J]. Cerebrovasc Dis，2009，

28（5）：435-438.

[53] YAMAMOTA Y，OHARA T，ISHII R，et al. A

combined treatment for acute larger lacunar-type

infarction [J]. J Stroke Cerebrovasc Dis，2011，20

（5）：387-394.